|
www.ChinaPost.com.tw |
|
|
|
|
U.S. government grants wider indication for anti-bleeding product The Food and Drug Administration said Friday it approved Humate-P for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease. Humate-P, a product made from human plasma, is manufactured by CSL Behring GmbH, Marburg, Germany. The company is a subsidiary of CSL Ltd. of Australia. Von Willebrand disease is the most common inherited bleeding disorder, affecting about 1 percent of the U.S. population, the FDA said. The FDA said Humate-P is approved for use in patients in whom the medication desmopressin may not work. Humate-P was originally approved for use in adult patients to treat and prevent bleeding from hemophilia, the agency said.
|
| Copyright © 1999 – 2009 The China Post. |
| Back to Story |